The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liang, B.
Right arrow Articles by Mamula, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liang, B.
Right arrow Articles by Mamula, M. J.
The Journal of Immunology, 00, 165: 3436-3443.
Copyright © 00 by The American Association of Immunologists

Autoantibody Responses and Pathology Regulated by B7-1 and B7-2 Costimulation in MRL/lpr Lupus1

Bailin Liang*, Michael J. Kashgarian{dagger}, Arlene H. Sharpe{ddagger} and Mark J. Mamula2,*

* Department of Internal Medicine, Section of Rheumatology, and {dagger} Department of Pathology and Biology, Yale University School of Medicine, New Haven, CT 06510; and {ddagger} Immunology Research Division, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115

The activation of T lymphocytes requires both Ag-mediated signaling through the TCR as well as costimulatory signals transmitted through B7-1 and/or B7-2 with CD28. The interference of B7-mediated costimulatory signals has been proposed as one immunotherapeutic intervention for the prevention autoimmune disease. This study has examined autoantibody responses and autoimmune pathology in a murine model of human systemic lupus erythematosus (SLE), the MRL-lpr/lpr mouse, genetically deficient in B7-1 or B7-2, or in mice treated with B7-1/B7-2 blocking Abs. In contrast to other studies of murine models of SLE, MRL-lpr/lpr mice treated with B7 blocking Abs exhibit strong anti-small nuclear ribonucleoprotein (snRNP) and anti-DNA autoantibody responses with some changes in isotype switching as compared with untreated animals. All MRL-lpr/lpr mice deficient in B7-1 or B7-2 produce anti-snRNP and anti-DNA titers with isotypes virtually identical with wild-type animals. However, the absence of B7-2 costimulation did interfere with the spontaneous activation and the accumulation of memory CD4+ or CD8+ T lymphocytes characteristic of wild-type MRL-lpr/lpr mice. IgG and C3 complement deposition was less pronounced in the kidneys of B7-2 deficient MRL-lpr/lpr mice, reflecting their lessor degree of glomerulonephritis. By comparison, B7-1-deficient MRL-lpr/lpr mice had more severe IgG and C3 deposits in glomeruli.




This article has been cited by other articles:


Home page
IOVSHome page
D. A. Jabs, R. A. Prendergast, A. L. Campbell, B. Lee, E. K. Akpek, H. C. Gerard, A. P. Hudson, and J. A. Whittum-Hudson
Autoimmune Th2-Mediated Dacryoadenitis in MRL/MpJ Mice Becomes Th1-Mediated in IL-4 Deficient MRL/MpJ Mice
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5624 - 5629.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. Odobasic, A. R. Kitching, T. J. Semple, J. R. Timoshanko, P. G. Tipping, and S. R. Holdsworth
Glomerular Expression of CD80 and CD86 Is Required for Leukocyte Accumulation and Injury in Crescentic Glomerulonephritis
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2012 - 2022.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Davidson, B Diamond, D Wofsy, and D Daikh
Block and tackle: CTLA4Ig takes on lupus
Lupus, March 1, 2005; 14(3): 197 - 203.
[Abstract] [PDF]


Home page
J. Immunol.Home page
K. M. Pollard, M. Arnush, P. Hultman, and D. H. Kono
Costimulation Requirements of Induced Murine Systemic Autoimmune Disease
J. Immunol., November 1, 2004; 173(9): 5880 - 5887.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Yadav, V. Judkowski, M. Flodstrom-Tullberg, L. Sterling, W. L. Redmond, L. Sherman, and N. Sarvetnick
B7-2 (CD86) Controls the Priming of Autoreactive CD4 T Cell Response against Pancreatic Islets
J. Immunol., September 15, 2004; 173(6): 3631 - 3639.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. G. Kevil, M. J. Hicks, X. He, J. Zhang, C. M. Ballantyne, C. Raman, T. R. Schoeb, and D. C. Bullard
Loss of LFA-1, but not Mac-1, Protects MRL/MpJ-Faslpr Mice from Autoimmune Disease
Am. J. Pathol., August 1, 2004; 165(2): 609 - 616.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Catterall, D. Stockwell, V. Marshall, A. Strasser, and J. Allison
Autoimmune kidney disease and lymphadenopathy in NODlpr mice are not modified by deficiency in tumor necrosis factor receptor 1 or {beta}2-microglobulin
Int. Immunol., June 1, 2003; 15(6): 679 - 690.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Yan and M. J. Mamula
B and T cell tolerance and autoimmunity in autoantibody transgenic mice
Int. Immunol., August 1, 2002; 14(8): 963 - 971.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Yamada, A. D. Salama, and M. H. Sayegh
The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575.
[Full Text] [PDF]


Home page
IOVSHome page
D. A. Jabs, R. A. Prendergast, E. M. Rorer, A. P. Hudson, and J. A. Whittum-Hudson
Cytokines in Autoimmune Lacrimal Gland Disease in MRL/MpJ Mice
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2567 - 2571.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.